POLEWACZYK JAMES F
SEC CIK 1389046 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IDXX | Idexx Laboratories | EVP | 10.7K | — | $25.20M | 14 | 2021-08-23 | 2024-03-06 |
Most active insiders at IDXX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | — | $15.34M |
| 2 | Hunt Nimrata | EVP | — | $9.53M |
| 3 | FENNELL GEORGE | EVP | — | $7.34M |
| 4 | Erickson Michael G | EVP | — | $3.37M |
| 5 | Kingsley Lawrence D | Dir | — | $1.17M |
| 6 | Vandebroek Sophie V. | Dir | — | $920.3K |
| 7 | Emerson Andrew | EVP, CFO, Treas | — | — |
| 8 | Schreck Michael | EVP | — | — |
| 9 | Johnson Michael Perkins | EVP | — | — |
| 10 | Peacock Karen | Dir | — | — |
POLEWACZYK JAMES F made no open-market trades at IDXX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-07 | 2024-03-06 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | S - Sale+OE | $558.44 | -8,104 | 10.7K | -43% | -$4.53M |
| DM | 2024-03-07 | 2024-03-06 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | M - OptEx | $422.45 | +8,104 | 11.5K | +241% | +$3.42M |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | +927 | 11.0K | +9% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | F - Tax | $560.56 | -279 | 10.7K | -3% | -$156.4K |
| DM | 2023-12-08 | 2023-12-07 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | M - OptEx | $253.92 | +11.6K | 21.7K | +116% | +$2.95M |
| DM | 2023-12-08 | 2023-12-07 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | S - Sale+OE | $521.79 | -11.6K | 15.2K | -43% | -$6.07M |
| DM | 2023-08-31 | 2023-08-29 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | S - Sale+OE | $510.56 | -22.9K | 32.4K | -41% | -$11.70M |
| DM | 2023-08-31 | 2023-08-29 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | M - OptEx | $144.21 | +16.9K | 19.4K | +687% | +$2.44M |
| DM | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | +834 | 16.6K | +5% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | F - Tax | $503.65 | +252 | 16.0K | +2% | +$126.9K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | +781 | 15.1K | +5% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | F - Tax | $505.53 | +235 | 15.4K | +2% | +$118.8K |
| 2021-12-01 | 2021-11-29 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | S - Sale | $633.00 | -4,595 | 14.8K | -24% | -$2.91M | |
| 2021-08-25 | 2021-08-23 | IDXX | Idexx Laboratories | POLEWACZYK JAMES F | EVP | G - Gift | $0.00 | -522 | 19.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations